Safety profile of guselkumab in treatment of patients with psoriasis and coexisting hepatitis B or C: A multicenter prospective cohort study

J Am Acad Dermatol. 2024 May;90(5):1083-1086. doi: 10.1016/j.jaad.2024.01.039. Epub 2024 Feb 1.

¹ Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
² Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
³ Department of Dermatology, National Taiwan University Hospital Hsin-Chu Branch, Hsin-chu, Taiwan; Department of Medical Research, National Taiwan University Hospital Hsin-Chu Branch, Hsin-chu, Taiwan; Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan; Department of Dermatology, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: extra.owl@gmail.com.

No abstract available

Keywords: guselkumab; hepatitis B; hepatitis C; psoriasis; reactivation.

Publication types